She almost didn’t tell me.

It came up nearly by accident, at the end of a routine visit for something else entirely — a knee pain, a general checkup her son had insisted on. As she was getting up to leave, she paused at the door and said, almost as an afterthought:

“Doctor, one small thing. Last month I saw a little spotting. Just once, for a day. It’s stopped now, so I didn’t think much of it.”

She was 58. Her periods had stopped eleven years ago.

I asked her to sit back down.

“How much blood, exactly?”

“Very little,” she said. “Like a light stain. I thought maybe it was piles, or maybe nothing at all. I wasn’t going to mention it, but my daughter-in-law said I should.”

I’m grateful, often, for daughters-in-law, daughters, and the occasional insistent son. Because here is the thing about bleeding after menopause: it doesn’t matter how little, how brief, or how long ago it happened. Even one spot, even once, is a reason to get checked. Not because it usually means something serious — most of the time, it doesn’t — but because we cannot know that without looking.

I explained this to her gently, because I could see her already retreating into “I’m sure it’s nothing, doctor, I don’t want to make a fuss.”

I hear that sentence often. Women who raised families, ran households, sat through decades of everyone else’s fevers and school exams and emergencies, have a way of quietly waving off their own symptoms. “It’s nothing.” “It will pass.” “I didn’t want to bother anyone.”

But a single episode of postmenopausal bleeding, however light, is one of the more important symptoms in gynaecology — precisely because the uterus has no business bleeding at all once periods have stopped for good. Most of the time, the cause turns out to be something benign — thinning of the vaginal lining, a small polyp, or hormone-related changes. But in a small proportion of women, it’s the first and sometimes only warning sign of endometrial cancer, which is very treatable when caught at this early stage.

That’s really the whole point of paying attention to it. Not fear — timing.

I did a simple ultrasound that day, looking specifically at the thickness of her uterine lining. It was mildly thickened, enough to warrant a closer look. I explained that the next step was a small procedure — a hysteroscopy with a biopsy — done as day care, nothing major, simply to look inside and take a tiny tissue sample to be sure.

She went quiet for a moment. “Is this because of the spotting? It really was so little.”

“That’s exactly why we’re doing it,” I told her. “Because it was there at all.”

Her biopsy, in the end, showed a benign polyp — nothing more. We removed it during the same procedure. She came back for her follow-up relieved, a little embarrassed at how anxious she’d been, and told me she’d already told her sister and two neighbours to “never ignore even one spot.”

Not every story ends this simply, which is exactly why the rule doesn’t bend: any bleeding after menopause — spotting, staining, a single episode, blood-tinged discharge — needs to be evaluated. Not eventually. Not “if it happens again.” The first time is enough.

If you’re a woman past menopause, or you have a mother, sister, mother-in-law, or neighbour who is, please pass this along: that “small thing” she almost didn’t mention is exactly the thing worth mentioning first.

Postmenopausal Bleeding: Causes, Evaluation, and When to See a Doctor

By Dr. Ramya D R, Gynaecological Oncologist

Menopause is defined as the point when a woman has gone 12 consecutive months without a menstrual period. Any vaginal bleeding after this point — whether it’s heavy, light, a single spot, or blood-tinged discharge — is termed postmenopausal bleeding (PMB), and it is never considered “normal.” Regardless of the amount or how briefly it occurs, it warrants medical evaluation.

Why Postmenopausal Bleeding Needs Attention

Around 90% of women with endometrial cancer present with postmenopausal bleeding as their first symptom, and it is the reason this particular symptom is treated with more urgency than most others in gynaecology. That said, the majority of PMB cases — roughly 90% by most estimates — turn out to have benign causes. The goal of evaluation is not to alarm, but to rule out malignancy early, when it is most treatable, while identifying and managing the more common benign causes.

Common Causes

Benign causes (the majority of cases):

• Endometrial or vaginal atrophy — thinning of the uterine lining or vaginal walls due to lower oestrogen levels; the single most common cause of PMB
• Endometrial or cervical polyps — small, usually benign growths that can bleed intermittently
• Hormone therapy — women on hormone replacement therapy may experience breakthrough bleeding
• Endometrial hyperplasia — thickening of the uterine lining, which can be a precursor to cancer in some cases and needs monitoring or treatment
• Infections or inflammation of the cervix or vagina

Malignant or premalignant causes (a minority, but the reason evaluation is essential):

• Endometrial cancer — the most common gynaecological cancer associated with PMB
• Cervical cancer
• Less commonly, ovarian or vaginal cancers

How Postmenopausal Bleeding Is Evaluated

A structured work-up typically involves:

1. History and examination — including a detailed menstrual and hormonal history, any use of HRT or tamoxifen, and a pelvic examination to inspect the cervix and vagina for visible causes.
2. Transvaginal ultrasound (TVS) — used to measure endometrial thickness. An endometrial thickness of 4 mm or less in a woman not on hormone therapy is generally reassuring, though this threshold is one part of the picture, not a standalone verdict.
3. Endometrial sampling — if the ultrasound is inconclusive, the lining is thickened, or bleeding recurs, a tissue sample is needed. This can be done as an outpatient endometrial biopsy or, more definitively, via hysteroscopy with biopsy, which also allows direct visualization of the uterine cavity and removal of polyps if present.
4. Further imaging or referral — if histology confirms hyperplasia with atypia or malignancy, further staging and referral to a gynaecologic oncologist follows.

Risk Factors Worth Knowing

Certain factors increase the likelihood of a malignant cause and often prompt a more thorough work-up:

• Obesity
• Diabetes and hypertension
• Late menopause (after age 55)
• Nulliparity (never having given birth)
• Tamoxifen use
• Unopposed oestrogen therapy
• Family history of endometrial, ovarian, or colorectal cancer (e.g., Lynch syndrome)

What Treatment Looks Like

Treatment is directed entirely by the underlying cause:

• Atrophy is often managed with topical or systemic oestrogen therapy
• Polyps are typically removed via hysteroscopy
• Hyperplasia may be managed with progestin therapy or, in some cases, surgery, depending on whether atypical cells are present
• Cancer, if diagnosed, is managed with a treatment plan individualized to the type and stage, often starting with surgery

The Key Takeaway

Postmenopausal bleeding should never be dismissed as insignificant, regardless of how minimal or brief it is. While the majority of cases have a benign explanation, timely evaluation is what allows the minority of cases — particularly endometrial cancer — to be caught at an early, highly treatable stage. Any woman experiencing bleeding after menopause should consult a gynaecologist promptly rather than waiting to see if it recurs.